Confusion between two drugs with sound-alike proprietary names, the antipsychotic quetiapine fumarate (Seroquel, AstraZeneca) and antidepressant nefazodone HCl (Serzone, Bristol-Meyers Squibb) has prompted AstraZeneca to send a "Dear Healthcare Professional" letter warning of the potential mix-up.
Get the latest industry news, event updates, and more from Managed healthcare Executive.